Rho Kinase Inhibitors for Glaucoma and Optic Neuropathy Treatment: Enzyme Activity, Cell Effects, IOP-Lowering and Neuroprotection Perspectives. OAJO [Internet]. 2022 Jan. 31 [cited 2026 Nov. 12];7(1):1-23. Available from: https://medwinpublisher.org/index.php/OAJO/article/view/10791